BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23136613)

  • 1. Gene expression patterns in the histopathological classification of epithelial ovarian cancer.
    Zhu H; Yu JJ
    Exp Ther Med; 2010 Jan; 1(1):187-192. PubMed ID: 23136613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
    Guo Y; Fu P; Zhu H; Reed E; Remick SC; Petros W; Mueller MD; Yu JJ
    Oncol Rep; 2012 Jan; 27(1):286-92. PubMed ID: 21971700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):834-9. PubMed ID: 18476518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 5. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY; Wei P; Qu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepant clinicopathologic characteristics and HE4 performance in type I and type II epithelial ovarian cancer.
    Jiang J; Bo D; Chang X; Cheng H; Ye X; Cui H
    Int J Clin Exp Med; 2015; 8(11):21303-10. PubMed ID: 26885070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.
    Zhou Q; Yu Y
    Med Sci Monit; 2015 Nov; 21():3409-14. PubMed ID: 26546806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
    Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
    Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
    Huang LP; Yu YH; Sheng C; Wang SH
    Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.
    Wang K; Guan C; Fang C; Jin X; Yu J; Zhang Y; Zheng L
    Oncol Lett; 2018 Apr; 15(4):4457-4462. PubMed ID: 29541214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.
    Wang D; Zhu H; Ye Q; Wang C; Xu Y
    Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
    Chien J; Fan JB; Bell DA; April C; Klotzle B; Ota T; Lingle WL; Gonzalez Bosquet J; Shridhar V; Hartmann LC
    Gynecol Oncol; 2009 Jul; 114(1):3-11. PubMed ID: 19410283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
    Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
    Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
    Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
    Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
    Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG; Edwards LS; Vanden Bergh PM; Hacker NF; Sutherland RL; O'Brien PM
    Clin Cancer Res; 2004 Jul; 10(13):4427-36. PubMed ID: 15240533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors.
    Garcia-Soto AE; Schreiber T; Strbo N; Ganjei-Azar P; Miao F; Koru-Sengul T; Simpkins F; Nieves-Neira W; Lucci J; Podack ER
    Gynecol Oncol; 2017 Jun; 145(3):413-419. PubMed ID: 28392126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
    Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
    Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.